Abstract
Background Multiple-breath nitrogen washout is an established and sensitive technique to assess functional residual capacity and ventilation inhomogeneity in the lung. Indirect calculation of nitrogen concentration requires precise calibration and accurate measurement of gas concentrations.
Aim We investigated the accuracy of the carbon dioxide gas concentration used for the indirect calculation of nitrogen concentration in a commercial multiple-breath washout (MBW) device (EasyOne Pro LAB, ndd Medizintechnik AG, Zurich, Switzerland) and its impact on outcomes.
Methods A high-precision calibration gas mixture was used to evaluate sensor output and calculated carbon dioxide concentration. We assessed the impact of a corrected CO2 signal on MBW outcomes in a dataset of healthy children and adults and children with lung disease.
Results The EasyOne device uses a respiratory quotient-based adjustment to correct the measured carbon dioxide signal for potential long-term changes in sensor output. In the majority of measurements (89%), this resulted in an overestimation of expired nitrogen concentrations (range -0.7 to 1.7%), and consequently MBW outcomes. Correction of the CO2 signal reduced the mean (range) cumulative expired volume by 27.1% (−58.1%; 1.0%), functional residual capacity by 11.1% (−21.6%; 1.2%), and lung clearance index by 18.3% (−44.0%; -0.3%). Additionally, within-visit variability was substantially reduced with the corrected signals.
Conclusion Inadequate signal-correction of the measured CO2 concentration in the EasyOne Pro LAB device leads to a non-systematic error in expired nitrogen concentrations and overestimation of test outcomes. Two-point calibration of the CO2 sensor may maintain accurate measurement of gas concentrations and overcome this error.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project was funded by the Swiss National Science Foundation (https://www.snf.ch/en/FKhU9kAtfXx7w9AI/page/home) Grant Nr. 182719 (P. Latzin) and 168173 (K. Ramsey).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Ethics Committee of the Canton of Bern, Switzerland approved the study protocol (2019-01072, 2019-01591) and participants or parents gave written consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.